Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Alvotech - Ordinary Shares (NQ:ALVO)

5.610 +0.270 (+5.06%)
Streaming Delayed Price Updated: 11:04 AM EDT, Sep 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Alvotech - Ordinary Shares

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Update on U.S. Regulatory Status of AVT02, Alvotech’s Proposed High-Concentration, Interchangeable Biosimilar to Humira®
From Alvotech
Via GlobeNewswire
News headline image
Correction to Total Amount in Announcement About Private Placement Published 2022-12-16 09:00 GMT to headline field
From Alvotech
Via GlobeNewswire
News headline image
Alvotech Completes $59.7 Million Private Placement
From Alvotech
Via GlobeNewswire
News headline image
Why Shares of Alvotech Jumped This Week ↗
The Icelandic biotech company has a deal to expand the reach of its Humira biosimilar in Eastern Europe. 
Via The Motley Fool
News headline image
4 Analysts Have This to Say About Alvotech ↗
Alvotech (NASDAQ:ALVO) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Alvotech Shares Start Trading on Nasdaq Iceland Main Market
From Alvotech
Via GlobeNewswire
News headline image
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC... 
Via Benzinga
News headline image
Alvotech and STADA Broaden Access to Hukyndra® adalimumab biosimilar in Europe
From Alvotech
Via GlobeNewswire
News headline image
Alvotech Announces Changes to its Leadership Team
From Alvotech
Via GlobeNewswire
News headline image
Alvotech Secures Financing Facilities of Approximately $136 Million
From Alvotech
Via GlobeNewswire
News headline image
Alvotech Reports Financial Results for First Nine Months of 2022 And Provides Business Update
From Alvotech
Via GlobeNewswire
News headline image
Earnings Scheduled For November 15, 2022 ↗
Companies Reporting Before The Bell • Alkaline Water Co (NASDAQ:WTER) is likely to report quarterly loss at $0.05 per share on revenue of $18.31 million. 
Via Benzinga
News headline image
Alvotech Announces Australian Marketing Authorization for AVT02, a Biosimilar to Humira®
From Alvotech
Via GlobeNewswire
News headline image
Alvotech to Present Switching Study Data for AVT02, a Proposed Biosimilar to Humira®, at 2022 American College of Rheumatology Conference
From Alvotech
Via GlobeNewswire
News headline image
Alvotech to Report First Nine Months Financial Results on November 15, 2022 and Host Business Update Conference Call at 8:00 am ET on November 16, 2022
From Alvotech
Via GlobeNewswire
News headline image
Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November
From Alvotech
Via GlobeNewswire
News headline image
Alvotech and JAMP Pharma Expand Exclusive Partnership Adding Two Biosimilar Candidates for Canadian Market, Bringing New Options for Patients in Specialty Care
From Alvotech
Via GlobeNewswire
News headline image
Alvotech’s Partner Submits Application for Marketing Approval of First Biosimilar Candidate in Japan
From Alvotech
Via GlobeNewswire
News headline image
Alvotech Appoints Sarah Tanksley as Chief Quality Officer
From Alvotech
Via GlobeNewswire
News headline image
Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares jumped 87% to $0.4791. Kiromic BioPharma, said on Sept. 15, that the company received letter from the Nasdaq that co. has been granted 180-day... 
Via Benzinga
News headline image
Domino's Pizza, Athersys And Some Other Big Stocks Moving Higher On Friday ↗
U.S. stocks traded lower, with the Dow Jones dropping around 400 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Earnings Scheduled For August 31, 2022 ↗
Companies Reporting Before The Bell • Hywin Holdings (NASDAQ:HYW) is expected to report earnings for its fourth quarter. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Tesla, Twitter And 76 Biggest Movers From Friday ↗
Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board... 
Via Benzinga
News headline image
Tesla, WD-40 Company And 40 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Aditxt, Inc. (NASDAQ: ADTX) shares surged 75.7% to $0.2812 after the company's Adimune therapeutic program completed a toxicology study indicating a favorable safety profile of ADI-100. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 1, 2022 ↗
Upgrades 
Via Benzinga
News headline image
This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday ↗
Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market. 
Via Benzinga
News headline image
Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday ↗
Gainers Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64. Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday. 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.